200,000+ products from a single source!

sales@angenechem.com

Home > Indoles and Oxindole > 180083-23-2

180083-23-2

180083-23-2 | Methanone, [2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl](2,5,6,7-tetrahydro-1'-methylspiro[3H-furo[2,3-f]indole-3,4'-piperidin]-5-yl)-

CAS No: 180083-23-2 Catalog No: AG0021OC MDL No:

Product Description

Catalog Number:
AG0021OC
Chemical Name:
Methanone, [2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl](2,5,6,7-tetrahydro-1'-methylspiro[3H-furo[2,3-f]indole-3,4'-piperidin]-5-yl)-
CAS Number:
180083-23-2
Molecular Formula:
C32H32N4O3
Molecular Weight:
520.6215
IUPAC Name:
[4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]phenyl]-(1'-methylspiro[6,7-dihydro-2H-furo[2,3-f]indole-3,4'-piperidine]-5-yl)methanone
InChI:
InChI=1S/C32H32N4O3/c1-20-16-25(30-33-21(2)39-34-30)8-9-26(20)22-4-6-23(7-5-22)31(37)36-13-10-24-17-29-27(18-28(24)36)32(19-38-29)11-14-35(3)15-12-32/h4-9,16-18H,10-15,19H2,1-3H3
InChI Key:
ATQMRMGXINTJHV-UHFFFAOYSA-N
SMILES:
CN1CCC2(CC1)COc1c2cc2c(c1)CCN2C(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C
UNII:
F95C648W4N

Properties

Complexity:
885  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
520.247g/mol
Formal Charge:
0
Heavy Atom Count:
39  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
520.633g/mol
Monoisotopic Mass:
520.247g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
71.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.6  

Literature

Title Journal
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters 20130801
5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes. Synapse (New York, N.Y.) 20121201
Tachyphylaxis to the sumatriptan-induced contractile effect in the human uterine artery but not in human cerebral blood vessels: pharmacological demonstration of the 5-HT(1B) receptor functionality loss. Pharmacology 20120101
5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats. Neuroscience letters 20111031
Relative contributions of 5-hydroxytryptamine (5-HT) receptor subtypes in 5-HT-induced vasoconstriction of the distended human saphenous vein as a coronary artery bypass graft. Biological & pharmaceutical bulletin 20110101
Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats. European journal of pharmacology 20100710
Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat. Behavioural brain research 20100105
Regulation of serotonin 1B receptor by glycogen synthase kinase-3. Molecular pharmacology 20091201
Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. European journal of pharmacology 20090801
Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats. Neuroscience letters 20090417
Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacology 20081201
Serotonin inhibits GABA synaptic transmission in presympathetic paraventricular nucleus neurons. Neuroscience letters 20080711
Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists. Journal of medicinal chemistry 20080522
Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model. Hippocampus 20080101
Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors. The international journal of neuropsychopharmacology 20071001
Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain : a journal of neurology 20070701
Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. British journal of pharmacology 20060901
5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats. Psychopharmacology 20060401
Synthesis of potent and selective serotonin 5-HT1B receptor ligands. Bioorganic & medicinal chemistry letters 20051101
The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Progress in neuro-psychopharmacology & biological psychiatry 20050601
The effects of SB 224289 on anxiety and cocaine-related behaviors in a novel object task. Physiology & behavior 20050413
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. European journal of pharmacology 20050307
Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats. British journal of pharmacology 20050301
Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain. Neuropharmacology 20050101
Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice. Psychopharmacology 20041001
In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist. European journal of pharmacology 20040919
Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex. Naunyn-Schmiedeberg's archives of pharmacology 20040801
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn-Schmiedeberg's archives of pharmacology 20040801
5-HT1B receptors, alpha2A/2C- and, to a lesser extent, alpha1-adrenoceptors mediate the external carotid vasoconstriction to ergotamine in vagosympathectomised dogs. Naunyn-Schmiedeberg's archives of pharmacology 20040701
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig. European journal of pharmacology 20040616
Tonic regulation of satiety by 5-HT receptors in the mouse: converging evidence from behavioural and c-fos immunoreactivity studies? The European journal of neuroscience 20040601
Increased expression of 5-HT1B receptor in dorsal raphe nucleus decreases fear-potentiated startle in a stress dependent manner. Brain research 20040508
Further characterization of the 5-HT1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT1B and 5-HT1D subtypes. Naunyn-Schmiedeberg's archives of pharmacology 20040201
Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences. Psychopharmacology 20040201
h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT. British journal of pharmacology 20030301
An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex. Naunyn-Schmiedeberg's archives of pharmacology 20030201
Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor. Pharmacology, biochemistry, and behavior 20030101
5-HT receptors mediating contraction in the rat-tail artery. Advances in experimental medicine and biology 20030101
Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life sciences 20021101
Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs. Naunyn-Schmiedeberg's archives of pharmacology 20020601
Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization. Pharmacology, biochemistry, and behavior 20020401
Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain research 20011005
The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. Journal of neurochemistry 20011001
Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase. European journal of pharmacology 20010713
The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. British journal of pharmacology 20010401
Could the 5-HT1B receptor inverse agonism affect learning consolidation? Neuroscience and biobehavioral reviews 20010301
Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms. Neuropharmacology 20010101
Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors. Naunyn-Schmiedeberg's archives of pharmacology 20010101
Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry. Molecular pharmacology 20001101
SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. British journal of pharmacology 19980901
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Journal of medicinal chemistry 19980409

Related Products

© 2019 Angene International Limited. All rights Reserved.